ArticleMicroorganisms2022
Therapy and Prevention for Human Toxocariasis.
Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- Human toxocariasis.Clinical microbiology reviews · 2025Pooled it
- Stage-specific gene expression profiling ofOpen veterinary journal · 2026Article
- Article
- Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stagesBiomedica : revista del Instituto Nacional de Salud · 2026Article
- Case Report: Toxocariasis as a rare trigger of vasculitis: a case-based review.Frontiers in immunology · 2026Review
- Toxocariasis in 62-year-old man with eosinophilia.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025Article
- Review
- First Report on the Seroprevalence and Risk Factors Associated withPathogens (Basel, Switzerland) · 2025Article
- Clinical Spectrum of Toxocariasis: A Retrospective Study From a Tertiary Care Center in Lebanon.Future microbiology · 2025Article
- Cloning, bioinformatics analysis, and expression of the ubiquitin 2 (ubq-2) gene from the dog roundwormFrontiers in veterinary science · 2025Article
- Toxocariasis in children: seroprevalence after 15 years in a major city in Brazil.Frontiers in pediatrics · 2025Article
- Infrared live imaging and navigated laser for nematode photocoagulation in a child with diffuse unilateral subacute neuroretinitis (DUSN).American journal of ophthalmology case reports · 2024Article
- Ultrastructural morphology of second and third-stage larvae ofOpen veterinary journal · 2024Article
- Larvicidal activity of coumarin derivatives on Toxocara canis larvae, cytotoxicity analysis, and in silico bioavailability studies.Parasitology research · 2024Article
- Evaluating the Toxocara cati extract as a therapeutic agent for allergic airway inflammation.Immunity, inflammation and disease · 2024Article
- Effects of metformin on parasitological, pathological changes in the brain and liver and immunological aspects during visceral toxocariasis in mice.Parasitology research · 2023Article
- Visceral larva Migrans in a Young Italian Patient: A Diagnostic Dilemma.Acta parasitologica · 2023Article
- Molecular investigation of Toxocara infection from the serum of people living with HIV in Alborz, Iran.BMC infectious diseases · 2023Article
- Seroprevalence of Toxocariasis and Its Associated Risk Factors among Adult Population in Kavar District, Fars Province, South of Iran: A Cross-Sectional Community-Based Seroepidemiological Survey.Interdisciplinary perspectives on infectious diseases · 2023Article
- Isolation and Production of Human Monoclonal Antibody Proteins against aPathogens (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the last four decades, knowledge about human toxocariasis with regard to its epidemiology, pathophysiology, clinical spectrum, and imaging or laboratory diagnosis has substantially progressed. Knowledge about specific therapy with anthelmintics has lagged behind. To date, only four drugs are registered for human use, and their efficacy has rarely been assessed in prospective controlled trials. It is likely that the repurposing of potent anthelmintics from veterinary medicine will improve this situation. Due to its wide availability and a lack of major side effects during short regimens, albendazole has become the drug of choice. However, its efficacy should be more precisely assessed. The role of anthelmintics in the treatment of neurological or ocular toxocariasis remains to be clarified. Prophylactic measures in humans or companion animals are efficient and represent first-line treatments for the control of this zoonosis. Unfortunately, their implementation in areas or countries where toxocariasis epidemiology is driven by poverty is quite difficult or unrealistic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.